White Paper

FDA Regulation Of Mobile Medical Apps

Source: NAMSA
Medical Apps

By Bruce A. MacFarlane, PhD

The past decade has witnessed rapid advancement in telecommunication and computer technologies. The smartphone is one result of that technological development and has been adopted by hundreds of millions of people worldwide. Innovators in the medical device industry quickly recognized the potential to use smartphones to expand the capabilities of healthcare professionals via mobile medical applications (“apps”) resident on these devices. These apps raise unique challenges for regulation by the Food and Drug Administration (FDA).

On July 21, 2011, FDA responded to the industry’s growing interest  in commercializing mobile medical apps by issuing a draft guidance document. On September 25, 2013 FDA issued its final guidance: Mobile Medical Applications Guidance for Industry and Food and Drug Administration Staff.

The guidance defines mobile apps that constitute medical devices. Next, FDA indicates the kinds of medical mobile apps for which the Agency will exercise “enforcement discretion,” meaning it will not enforce the applicable requirements of the Food, Drug, and Cosmetics Act. It then outlines regulatory requirements and closes with appendices focusing on examples to illustrate the principles of the guidance.

VIEW THE WHITE PAPER!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Med Device Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: